Interestingly, a study using a xenografted mice melanoma model has reported a vascular remodeling process which is mediated by the transduction signaling of the IGF1/IGF1R axis, contributing to the development of the melanoma cells which have acquired resistance to BRAF inhibition. The gene discussed is IGF1; the disease is melanoma.